Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Diabetes

Free Subscription 15.12.2025 1 Am Heart J 3 Am J Ophthalmol 1 Ann Intern Med 1 Biochem Biophys Res Commun 1 BMC Ophthalmol 11 Diabet Med 1 Diabetes 32 Diabetes Care 13 Diabetes Obes Metab 7 Diabetologia 1 Hypertension 1 Invest Ophthalmol Vis Sci 1 J Am Coll Cardiol 3 J Clin Endocrinol Metab 1 J Clin Invest 4 J Diabetes Complications 2 J Nutr 1 JAMA 1 Nature 1 Obstet Gynecol 3 Pediatr Diabetes 1 PLoS Comput Biol 10 PLoS One 1 Proc Natl Acad Sci U S A 1 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. YOSHIDA Y, Zu Y, Aguilar D, Ferdinand KC, et al
   Cumulative effect of hyperglycemia and insulin resistance on cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
   Am Heart J. 2026;292:107276.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

2. HONG AT, Lin F, Baxter S, Weinreb RN, et al
   Tirzepatide is Associated with Reduced Risk of Primary Open-Angle Glaucoma and Ocular Hypertension in Patients with Type 2 Diabetes.
   Am J Ophthalmol. 2025 Dec 6:S0002-9394(25)00653.
   PubMed         Abstract available
   
   
3. AHUJA AS, Paredes AA 3rd, Ahuja SA, Young BK, et al
   Glucagon-like Peptide-1 Receptor Agonist Use and Risk of Cataract Development.
   Am J Ophthalmol. 2025 Oct 21:S0002-9394(25)00558.
   PubMed         Abstract available
   
   
4. PAN SY, Weng CH, Tsai SF, Sheen YJ, et al
   Comparative Risk of Glaucoma in Patients Using Sodium-glucose Cotransporter-2 Inhibitors and Metformin: A Multinational Cohort Study.
   Am J Ophthalmol. 2025 Sep 19:S0002-9394(25)00504.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

5. LIBMAN H, LaSalvia MT, Rosenblum BI, Reynolds EE, et al
   How Would You Manage This Diabetic Patient With a Foot Infection? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med. 2025 Dec 9. doi: 10.7326/ANNALS-25-04326.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

6. HUANG Z, Zhang Y, Tian J, Song P, et al
   Engineered MSCs secreting GLP-1 enhance beta-cell survival and improve glycemic control in diabetic mice.
   Biochem Biophys Res Commun. 2025;795:153105.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

7. KU JY, Knox PC, Czanner G, Parry DG, et al
   Functional and structural biomarkers linked to diabetic retinal neurodegeneration in pre-clinical and early diabetic retinopathy.
   BMC Ophthalmol. 2025 Dec 10. doi: 10.1186/s12886-025-04564.
   PubMed        
   
   

   
   Diabet Med

8. HOUSBY H, Kaur A, Wylie T, Oliver N, et al
   'They use the little information they have to pass judgement': A framework analysis of type 1 diabetes stigma experienced by UK adults living with type 1 diabetes.
   Diabet Med. 2025 Dec 13:e70191. doi: 10.1111/dme.70191.
   PubMed         Abstract available
   
   
9. CHAHAL T, Alexandre-Heymann L, Yardley JE, Grou C, et al
   Automated insulin delivery system use and physical activity levels in adults with type 1 diabetes: A BETTER registry analysis.
   Diabet Med. 2025 Dec 13:e70192. doi: 10.1111/dme.70192.
   PubMed         Abstract available
   
   
10. DAFFAALLAH H, Khan S, Hughes M, Jude E, et al
    Unmasking the pain in a diabetic foot.
    Diabet Med. 2025 Dec 12:e70166. doi: 10.1111/dme.70166.
    PubMed        
    
    
11. PENA D, Medina Penaranda R, Figg LE, Hood KK, et al
    "The pump is one thing... but you should walk out of the hospital with a [sensor]": Perceptions on diabetes technology from minoritized caregivers in the US.
    Diabet Med. 2025 Dec 10:e70189. doi: 10.1111/dme.70189.
    PubMed         Abstract available
    
    
12. SCARAMUZZA AE, Bonfanti R, Rabbone I
    Glycaemic outcomes of a 4-h insulin pump suspension for prolonged exercise in youth with type 1 diabetes.
    Diabet Med. 2025 Dec 9:e70180. doi: 10.1111/dme.70180.
    PubMed        
    
    
13. SAPKOTA S, Rai P, Karmacharya B, Bhattarai J, et al
    Implementation of a remission diet for type 2 diabetes in South Asia: Qualitative evidence from the HoDiRECT Nepal project.
    Diabet Med. 2025 Dec 7:e70184. doi: 10.1111/dme.70184.
    PubMed         Abstract available
    
    
14. SCHOENAKER D, Dyer E, Heslehurst N, Kent G, et al
    Associations of modifiable preconception, pregnancy and postpartum factors with health outcomes for women with type 2 diabetes and their children: A systematic review and meta-analysis of observational studies.
    Diabet Med. 2025 Dec 7:e70183. doi: 10.1111/dme.70183.
    PubMed         Abstract available
    
    
15. KRISTENSEN CB, Asimakopoulou K, Ide M, Forbes A, et al
    Barriers and facilitators to oral healthcare support in gestational diabetes mellitus: An interview study with healthcare professionals.
    Diabet Med. 2025 Dec 7:e70181. doi: 10.1111/dme.70181.
    PubMed         Abstract available
    
    
16. BRINKMANN MLS, Krasilnikoff NJ, Chaaban MA, Luef BM, et al
    Metformin safety during pregnancy in women with gestational diabetes mellitus: A systematic review and meta-analysis of maternal, neonatal and long-term outcomes.
    Diabet Med. 2025 Dec 7:e70173. doi: 10.1111/dme.70173.
    PubMed         Abstract available
    
    
17. LAU SM, Popovic G, Maslen B, Depczynski B, et al
    Early, unplanned readmission in diabetes inpatients: Comparing the utility and performance of machine learning and traditional prediction models to guide timely diabetes management team review.
    Diabet Med. 2025 Dec 6:e70186. doi: 10.1111/dme.70186.
    PubMed         Abstract available
    
    
18. PAN A, Wu H, Wang Q, Zhang S, et al
    Isoastragaloside I improves hyperglycaemia and increases beta-cell mass in mice.
    Diabet Med. 2026;43:e70162.
    PubMed         Abstract available
    
    

    
    Diabetes

19. TRIOLO TM, Sosenko JM, Cuthbertson D, Oram RA, et al
    Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.
    Diabetes. 2025 Dec 10:db250711. doi: 10.2337/db25-0711.
    PubMed         Abstract available
    
    

    
    Diabetes Care

20. MANN JFE, Marx N, Deanfield JE, Emerson SS, et al
    Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.
    Diabetes Care. 2025 Dec 4:dc251080. doi: 10.2337/dc25-1080.
    PubMed         Abstract available
    
    
21. CHATTY P, Gera S, Rearson A, Mountain JN, et al
    Effect of Low Bolus Frequency on Automated Insulin Delivery System Performance in Youth With Type 1 Diabetes.
    Diabetes Care. 2025 Dec 11:dc252082. doi: 10.2337/dc25-2082.
    PubMed         Abstract available
    
    
22. KOSTRZEWSKA P, Kuca P, Laz R, Maksymiuk-Klos A, et al
    Early-Onset Fibrocalculous Pancreatic Diabetes Associated With SPINK1 Variants in Trans: A Rare Genetic Case.
    Diabetes Care. 2025 Dec 11:dc252135. doi: 10.2337/dc25-2135.
    PubMed        
    
    
23. JOSEFSON JL, King AS, Sun B, Quesenberry CP Jr, et al
    Midchildhood Obesity After Exposure to Gestational Diabetes Mellitus: The SWIFT Study in Youth.
    Diabetes Care. 2025 Dec 11:dc251093. doi: 10.2337/dc25-1093.
    PubMed         Abstract available
    
    
24. ODEGAARD AO, Chang J, Jiang L, Rashid S, et al
    The Effect of Substituting Water for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial.
    Diabetes Care. 2025 Dec 10:dc251516. doi: 10.2337/dc25-1516.
    PubMed         Abstract available
    
    
25. NITECKI M, Vinograd A, Bardugo A, Bendor C, et al
    Normal-Range Gestational Glucose Challenge Test and Incident Type 2 Diabetes: A Population-Based Cohort Study.
    Diabetes Care. 2025 Dec 9:dc252450. doi: 10.2337/dc25-2450.
    PubMed        
    
    
26. FORTMAN E, Field C, Wu J, Vickers S, et al
    Pregnancy Outcomes in Individuals With Young-Onset Type 2 Diabetes.
    Diabetes Care. 2025 Dec 9:dc252342. doi: 10.2337/dc25-2342.
    PubMed        
    
    
27. YOU L, Parikh HM, Triolo TM, Ferrat LA, et al
    Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention.
    Diabetes Care. 2025 Dec 9:dc252006. doi: 10.2337/dc25-2006.
    PubMed         Abstract available
    
    
28. THAI NQN, Chun LF, Newton KP, Wilson L, et al
    Longitudinal Analysis of Liver Chemistry Trajectories and Risk of Type 2 Diabetes in Children With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Cohort Study.
    Diabetes Care. 2025 Dec 9:dc251532. doi: 10.2337/dc25-1532.
    PubMed         Abstract available
    
    
29. OSTROMINSKI JW, Lu H, Claggett BL, Desai AS, et al
    Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Diabetes Care. 2026 Dec 8:dc252540. doi: 10.2337/dc25-2540.
    PubMed        
    
    
30. 
    9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
31. 
    10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
32. 
    5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
33. 
    4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
34. 
    Summary of Revisions: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed        
    
    
35. 
    17. Diabetes Advocacy: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
36. 
    6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
37. 
    2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
38. 
    16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
39. 
    3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
40. 
    14. Children and Adolescents: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
41. 
    7. Diabetes Technology: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
42. 
    13. Older Adults: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
43. 
    1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
44. 
    12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
45. 
    15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
46. 
    Introduction and Methodology: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed        
    
    
47. 
    8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
48. 
    11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed         Abstract available
    
    
49. YU J, Cho JH, Han K, Park YM, et al
    Reproductive Lifespan and Reproductive Factors in Relation to Dementia Risk in Postmenopausal Women With Type 2 Diabetes.
    Diabetes Care. 2025 Dec 5:dc251961. doi: 10.2337/dc25-1961.
    PubMed         Abstract available
    
    
50. BECK RW, Hirsch IB, Raghinaru D, Lum JW, et al
    Automated Insulin Delivery Is Beneficial in Adults With Insulin-Treated Type 2 Diabetes With and Without GAD65 Antibodies.
    Diabetes Care. 2025 Dec 5:dc252059. doi: 10.2337/dc25-2059.
    PubMed        
    
    
51. DECKER SRR, Chaudhary RS, Inoue K, Song Y, et al
    Socioeconomic Factors and Initiation of Semaglutide or Tirzepatide Among Medicare Beneficiaries With Type 2 Diabetes.
    Diabetes Care. 2025 Dec 5:dc251619. doi: 10.2337/dc25-1619.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

52. HARBI H, Carney G, Dormuth C, Stidsen JV, et al
    Use of sodium-glucose cotransporter-2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia.
    Diabetes Obes Metab. 2025 Dec 12. doi: 10.1111/dom.70375.
    PubMed         Abstract available
    
    
53. LEI M, Zhou Y, Ni Y, Lin Z, et al
    Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta-analysis of randomised trials.
    Diabetes Obes Metab. 2025 Dec 12. doi: 10.1111/dom.70355.
    PubMed         Abstract available
    
    
54. CHENG AYY, Anil G, Canani L, Vinther S, et al
    Efficacy and hypoglycaemia outcomes of once-weekly insulin icodec versus once-daily basal insulin comparators across baseline HbA1c, BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1-5.
    Diabetes Obes Metab. 2025 Dec 12. doi: 10.1111/dom.70358.
    PubMed         Abstract available
    
    
55. BHADURI G, Samajdar SS, Bandyopadhyay S, Mukherjee S, et al
    Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, MASLD, and Stage 3 chronic kidney disease: A 12-month observational study.
    Diabetes Obes Metab. 2025 Dec 10. doi: 10.1111/dom.70370.
    PubMed        
    
    
56. JAIN A, Kristensen PN, Wasehuus RS, Kruse C, et al
    Clinical implications of intentional weight loss in people living with type 2 diabetes: A real-world database study.
    Diabetes Obes Metab. 2025 Dec 10. doi: 10.1111/dom.70350.
    PubMed         Abstract available
    
    
57. 
    Correction to "An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats".
    Diabetes Obes Metab. 2025 Dec 9. doi: 10.1111/dom.70372.
    PubMed        
    
    
58. DRAI R, Galstyan G, Karonova T, Protsenko E, et al
    Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial.
    Diabetes Obes Metab. 2025 Dec 9. doi: 10.1111/dom.70360.
    PubMed         Abstract available
    
    
59. YEN FS, Wei JC, Lu WY, Yen YH, et al
    Income-related inequities in the progression from gestational to type 2 diabetes: Findings from Taiwan's maternal and child health database.
    Diabetes Obes Metab. 2025 Dec 9. doi: 10.1111/dom.70367.
    PubMed         Abstract available
    
    
60. STIMSON RH, Crane MS, Dover AR, Forbes S, et al
    CGM-derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes.
    Diabetes Obes Metab. 2025 Dec 9. doi: 10.1111/dom.70365.
    PubMed         Abstract available
    
    
61. DHIPPAYOM T, Meraz M, Lee H, Hur C, et al
    GLP-1 receptor agonists for treating obesity without diabetes: A systematic review and meta-analysis of economic evaluations.
    Diabetes Obes Metab. 2025 Dec 9. doi: 10.1111/dom.70322.
    PubMed         Abstract available
    
    
62. RUSSELL-JONES D, Smout V, Roy S, Myers G, et al
    A novel glucose beta-hydroxybutyrate combination improves hypoglycaemia recovery and patient-reported outcomes in type 1 diabetes.
    Diabetes Obes Metab. 2025 Dec 8. doi: 10.1111/dom.70323.
    PubMed         Abstract available
    
    
63. JANSSON AK, Schumacher TL, Oldmeadow C, Grotowski M, et al
    The impact of telehealth-delivered Medical Nutrition Therapy on diabetes outcomes in rural general practice: A secondary analysis of the Healthy Rural Hearts randomised controlled trial.
    Diabetes Obes Metab. 2025 Dec 5. doi: 10.1111/dom.70339.
    PubMed         Abstract available
    
    
64. WANG Y, Wang S, Wang W, Li X, et al
    Low immunogenicity of insulin efsitora alfa in participants with type 1 and type 2 diabetes mellitus.
    Diabetes Obes Metab. 2025 Dec 4. doi: 10.1111/dom.70325.
    PubMed         Abstract available
    
    

    
    Diabetologia

65. WANG Y, Ram J, Bianchi C, Fiorentino TV, et al
    Superiority of 1 h plasma glucose vs fasting plasma glucose, 2 h plasma glucose and HbA(1c) for the diagnosis of type 2 diabetes.
    Diabetologia. 2025 Dec 12. doi: 10.1007/s00125-025-06632.
    PubMed         Abstract available
    
    
66. DAVOODIAN N, Lotfaliany M, Huxley RR, Lee CMY, et al
    Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk. Reply to Choi W [Letter].
    Diabetologia. 2025 Dec 12. doi: 10.1007/s00125-025-06641.
    PubMed        
    
    
67. LI X, Gong H, Xiong C, Huang X, et al
    LDHA induces beta cell dedifferentiation in diabetes through metabolic and epigenetic reprogramming.
    Diabetologia. 2025 Dec 11. doi: 10.1007/s00125-025-06626.
    PubMed         Abstract available
    
    
68. THIRUMATHYAM R, Richter EA, van Hall G, Andersen NR, et al
    Empagliflozin improves beta cell function independently of relief of glucotoxicity in patients with type 2 diabetes: results from a randomised cross-over study with insulin as comparator.
    Diabetologia. 2025 Dec 9. doi: 10.1007/s00125-025-06616.
    PubMed         Abstract available
    
    
69. MCCARTHY OM, Brodsgaard RB, Tawfik S, Lundemose SB, et al
    Impact of cardiovascular autonomic neuropathy on cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes.
    Diabetologia. 2025 Dec 9. doi: 10.1007/s00125-025-06619.
    PubMed         Abstract available
    
    
70. VEIJOLA R, Tamura RN, Clasen JL, Elding Larsson H, et al
    Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity.
    Diabetologia. 2025 Dec 8. doi: 10.1007/s00125-025-06613.
    PubMed         Abstract available
    
    
71. SINKE L, Delerue T, Wilson R, Lu X, et al
    DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease.
    Diabetologia. 2026;69:127-145.
    PubMed         Abstract available
    
    

    
    Hypertension

72. SRIDHAR VS, Kugathasan L, Lytvyn Y, Deng Y, et al
    Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Hypertension. 2025 Dec 5. doi: 10.1161/HYPERTENSIONAHA.125.25955.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

73. HU W, Yang H, Zhu Q, Zheng G, et al
    KLF10-IN-1 Attenuates RPE Cell Apoptosis and Experimental Diabetic Retinopathy Via the KLF10/PERK/eIF2alpha/ATF4/CHOP Pathway.
    Invest Ophthalmol Vis Sci. 2025;66:25.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

74. OSTROMINSKI JW, Neuen BL, Claggett BL, Filippatos G, et al
    Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)10071.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

75. SOJAKKA SMITH E, Franzen A, Pihlsgard M, M Nilsson P, et al
    Nocturnal melatonin secretion and risk of type 2 diabetes: a prospective cohort study.
    J Clin Endocrinol Metab. 2025 Dec 13:dgaf667. doi: 10.1210.
    PubMed         Abstract available
    
    
76. TANABE H, Shimajiri Y, Shiroma K, Higa M, et al
    Unequal distribution of plasma glucagon levels among clustering-based diabetes subtypes: a Japanese cohort.
    J Clin Endocrinol Metab. 2025 Dec 13:dgaf654. doi: 10.1210.
    PubMed         Abstract available
    
    
77. NIELSEN SW, Gilliam-Vigh H, Jorsal T, Wahlgren CD, et al
    Distribution of Somatostatin and its Receptors in the Intestinal Tract in Healthy and in Patients with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Dec 11:dgaf648. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

78. HUANG X, Liu M, Gonzalez MV, Debnath R, et al
    Diabetes exacerbates destructive inflammation by activating theCD137L-CD137 axis in dendritic and gammadelta T-cells.
    J Clin Invest. 2025 Dec 11:e193289. doi: 10.1172/JCI193289.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

79. DO LK, Kuo CY, Misra SL, Murphy R, et al
    Linking HbA1c and white blood cell counts to the development of diabetic macular edema in type 2 diabetes: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;40:109237.
    PubMed         Abstract available
    
    
80. ZHANG Y, Hu W, Wang D, Zhang H, et al
    Association of atherogenic index of plasma baselines and trajectories with the progression from prediabetes to diabetes.
    J Diabetes Complications. 2025;40:109238.
    PubMed         Abstract available
    
    
81. WU JT, Li YH, Cheng YC, Shu KH, et al
    Variability in the urinary albumin-to-creatinine ratio predicts mortality in patients with type 2 diabetes.
    J Diabetes Complications. 2025;40:109249.
    PubMed         Abstract available
    
    
82. ROMA-WILSON MA, Pozzilli P
    Corrigendum to 'What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?' [JDC, Vol. 39, Issue 10, October 2025, 109132].
    J Diabetes Complications. 2025 Dec 3:109230. doi: 10.1016/j.jdiacomp.2025.109230
    PubMed         Abstract available
    
    

    
    J Nutr

83. SU R, Zhou X, Steffen LM, Chen C, et al
    Identifying the Ratio of Circulating Cinnamoylglycine to Isoleucine as a Biomarker Linking Diet Quality, Microbial Metabolism, and Type 2 Diabetes Risk in the CARDIA Cohorts.
    J Nutr. 2025 Dec 8:101260. doi: 10.1016/j.tjnut.2025.101260.
    PubMed         Abstract available
    
    
84. FERNANDEZ-FIGARES JIMENEZ MDC
    Postprandial blood glucose-focused dietary approaches and their limitations.
    J Nutr. 2025 Oct 3:S0022-3166(25)00610-8. doi: 10.1016/j.tjnut.2025.
    PubMed         Abstract available
    
    

    
    JAMA

85. ANDERER S
    WHO Releases First Global Guidelines for Diabetes Management in Pregnancy.
    JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20013.
    PubMed        
    
    

    
    Nature

86. WEI Q, He Z, Li Z, Zhou Z, et al
    A skin-permeable polymer for non-invasive transdermal insulin delivery.
    Nature. 2025;648:459-467.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

87. ROWE JC 4TH, Scaglione M, Ma'ayeh M, Saade G, et al
    Diagnosis and Management of Euglycemic Diabetic Ketoacidosis in Pregnancy.
    Obstet Gynecol. 2025 Dec 11. doi: 10.1097/AOG.0000000000006143.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

88. BENSKIN GA, Lashley PM
    Exploring the Influence of a Diabetes Specialty Outpatient Clinic on Adolescents With Type 1 Diabetes in Barbados: A Qualitative Study.
    Pediatr Diabetes. 2025;2025:5454172.
    PubMed         Abstract available
    
    
89. SANRI A, Cetin TK, Acikgoz EG, Mutlu MB, et al
    Revealing Monogenic Diabetes: Clinical and Genetic Features of Pediatric MODY Cases in Turkiye: Single Center Experience.
    Pediatr Diabetes. 2025;2025:4035026.
    PubMed         Abstract available
    
    
90. EZZATVAR Y, Hormazabal-Aguayo I, Munoz-Pardeza J, Paez-Herrera J, et al
    Global Prevalence of Microvascular Complications in Children and Adolescents With Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Pediatr Diabetes. 2025;2025:8398194.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

91. AKTER Z, Ahad J, Farhan MM, Khan R, et al
    Graph-enhanced deep learning for diabetic retinopathy diagnosis: A quality-aware and uncertainty-driven approach.
    PLoS Comput Biol. 2025;21:e1013745.
    PubMed         Abstract available
    
    

    
    PLoS One

92. THAHIEM S, Ihsan M, Muneer H, Sohail A, et al
    Correction: Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study.
    PLoS One. 2025;20:e0338855.
    PubMed         Abstract available
    
    
93. JIANG L, Jia J, Chen T, Xu L, et al
    High BMI-attributed diabetic kidney disease in China versus globally, 1990-2021, with projections to 2045: Divergent trends and an accelerating burden.
    PLoS One. 2025;20:e0338118.
    PubMed         Abstract available
    
    
94. LI T, Wang H, Chang B, Lu H, et al
    Grape seed proanthocyanidin extract inhibits ferroptosis by activating Nrf2/HO-1 and protects against diabetic kidney disease.
    PLoS One. 2025;20:e0336472.
    PubMed         Abstract available
    
    
95. ZHAO L, Zhang J, Liu W, Dai C, et al
    GV effects of diabetes mellitus on clinical outcomes of patients with acute heart failure: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0338653.
    PubMed         Abstract available
    
    
96. AMARAVADI SK, Ferreira AS, Vigario PDS
    Comparative effects of combined aerobic and resistance training versus high-intensity interval training on insulin resistance, glycaemic control, body composition and quality of life in type 2 diabetes: A 12-week randomised controlled trial.
    PLoS One. 2025;20:e0336898.
    PubMed         Abstract available
    
    
97. FREIHAT O, Sipos D, Aamir M, Kovacs A, et al
    Global burden and future projections of non-communicable diseases (2000-2050): Progress toward SDG 3.4 and disparities across regions and risk factors.
    PLoS One. 2025;20:e0336036.
    PubMed         Abstract available
    
    
98. NIZAM AM
    Minimum Displacement in Existing Moment (MDEM)- A new supervised learning algorithm by incrementally constructing the moments of the underlying classes.
    PLoS One. 2025;20:e0336933.
    PubMed         Abstract available
    
    
99. ASCHALEW AY, Kelkay JM, Teshale G, Demissie KA, et al
    Availability and readiness of health facilities for non-communicable disease services in Ethiopia: Evidence from the nationally representative health facility survey 2022.
    PLoS One. 2025;20:e0336675.
    PubMed         Abstract available
    
    
100. JOYCE OC, McHugh C, Mocker D, Wilson F, et al
     The influence of type 2 diabetes and its metabolic correlates in middle-aged adults on cognition at mid and later life; A systematic review and meta-analysis.
     PLoS One. 2025;20:e0327408.
     PubMed         Abstract available
     
     
101. CHEN Y, Hu R, Li E, Li G, et al
     Circular RNA FTO functions as a hsa-miR-141-3p sponge to regulate the growth and migration abilities of human retinal endothelial cells via up-regulating ZEB1.
     PLoS One. 2025;20:e0338208.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

102. CHEN D, Wang J, Song XJ, Ding ZJ, et al
     Galectin-related protein, a key contributor, drives diabetes-associated neuropathic pain.
     Proc Natl Acad Sci U S A. 2025;122:e2527641122.
     PubMed         Abstract available
     
     

     
     Retina

103. LI B, Li S, Cun Y
     The Efficacy and Safety of Subretinal Balanced Salt Solution Injection in Diabetic Macular Edema with Hard Exudates.
     Retina. 2025 Nov 26. doi: 10.1097/IAE.0000000000004742.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.